Purchase Order 75N91018P00399

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an Ion Library Quantitation Kit on June 26, 2019, with a ceiling value of $13,879.50. Performance is scheduled to complete by July 26, 2019, with work performed in Carlsbad, California. The order covers a single unit of catalog item A26121ION at firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $8,120.00 on July 3, 2018, for one ION AMPLISEQ LIB KIT 2.0 (catalog A26120). Performance is at Bethesda, Maryland. The order carries firm fixed pricing and completed July 31, 2018. No set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for ION 540 chip kits at $13,504.05 on April 2, 2019, with completion due May 2, 2019. Performance occurs at the vendor's Carlsbad, California facility. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $5,611.84 on July 11, 2017, with ultimate completion on August 16, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for laboratory instrumentation, reagents, consumables, or maintenance services typical of Life Technologies' federal portfolio in life-sciences research and diagnostic infrastructure. Pricing is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an Oncomine Comprehensive Manual Combo Kit (catalog A35805) valued at $17,100.00 on August 7, 2018, with completion by September 30, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for the Oncomine Comprehensive Manual Combo Kit (catalog A35805) valued at $17,100.00, with an award date of August 6, 2018 and completion date of September 30, 2018. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation on August 5, 2015, valued at $3,011.04 for scientific instruments, reagents, or consumables with a firm fixed price structure. Performance occurred in Baltimore, Maryland, with an ultimate completion date of September 28, 2016. No set-aside applied to this simplified acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $24,898.13 on August 30, 2018, with ultimate completion on August 29, 2019. No set-aside category applied. Place of performance is Bethesda, Maryland. The purchase order uses fixed-price pricing with economic price adjustment. Life Technologies operates as Thermo Fisher Scientific and supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs.</p>